Herpes Simplex Virus Suppressive Therapy Decreases Plasma and Genital HIV-1 Levels in HSV-2/HIV-1 Co-infected Women: A Randomized, Placebo-Controlled, Cross-Over Trial

A randomized cross-over trial of HSV-2 suppressive therapy was conducted among 20 HSV-2/HIV-1 co-infected Peruvian women not on antiretroviral therapy. Participants were assigned valacyclovir 500 mg twice daily or placebo for 8 weeks, then after a 2 week washout, the alternative for 8 weeks. Plasma...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Baeten, Jared M., Strick, Lara B., Lucchetti, Aldo, Whittington, William L. H., Sanchez, Jorge, Coombs, Robert W., Magaret, Amalia, Wald, Anna, Corey, Lawrence, Celum, Connie
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2008
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2665183/
https://ncbi.nlm.nih.gov/pubmed/18928378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/593214
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg